These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34191497)

  • 21. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
    Li Y; Zhang Z
    Sci Rep; 2014 Nov; 4():7097. PubMed ID: 25403569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-miRNA oligonucleotides: A comprehensive guide for design.
    Lima JF; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    RNA Biol; 2018 Mar; 15(3):338-352. PubMed ID: 29570036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA replacement therapy in cancer.
    Mollaei H; Safaralizadeh R; Rostami Z
    J Cell Physiol; 2019 Aug; 234(8):12369-12384. PubMed ID: 30605237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential microRNA targets for cancer chemotherapy.
    Tan S; Wu Y; Zhang CY; Li J
    Curr Med Chem; 2013; 20(29):3574-81. PubMed ID: 23834181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
    Connelly CM; Deiters A
    Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery.
    Esposito CL; Catuogno S; de Franciscis V
    Methods Mol Biol; 2016; 1364():197-208. PubMed ID: 26472452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of microRNAs for potential cancer therapeutics.
    Wu W
    Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanobody-guided targeted delivery of microRNA via nucleic acid nanogel to inhibit the tumor growth.
    Zhang Q; Ding F; Liu X; Shen J; Su Y; Qian J; Zhu X; Zhang C
    J Control Release; 2020 Dec; 328():425-434. PubMed ID: 32889054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ChrXq27.3 miRNA cluster functions in cancer development.
    Yoshida K; Yokoi A; Yamamoto Y; Kajiyama H
    J Exp Clin Cancer Res; 2021 Mar; 40(1):112. PubMed ID: 33766100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of extracellular vesicle microRNAs in cancer biology.
    Takahashi RU; Prieto-Vila M; Hironaka A; Ochiya T
    Clin Chem Lab Med; 2017 May; 55(5):648-656. PubMed ID: 28231055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.
    Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF
    Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathways: microRNAs as cancer therapeutics.
    Melo SA; Kalluri R
    Clin Cancer Res; 2012 Aug; 18(16):4234-9. PubMed ID: 22711704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
    Paskeh MDA; Mirzaei S; Orouei S; Zabolian A; Saleki H; Azami N; Hushmandi K; Baradaran B; Hashmi M; Aref AR; Ertas YN; Zarrabi A; Ashrafizadeh M; Samarghandian S
    Int J Biol Macromol; 2021 Nov; 191():727-737. PubMed ID: 34562537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.
    Gu DN; Huang Q; Tian L
    Expert Opin Ther Targets; 2015 Mar; 19(3):415-26. PubMed ID: 25434362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
    Hon LS; Zhang Z
    Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.